Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
Clinical trial NCT04815187 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04815187
- Sponsor
- House Ear Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2025-09-03
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.